- Country: Ukraine
- Summary: A Set of Reagents for the Detection of Antibodies to the Hepatitis C Virus (Anti-Hcv), Compatible with Architect, Package, 0, Research Material Plasma, the Architect I2000Sr Device, Number of Tests in the Package 2000; Nab...
- UAT Ref No: 131095467
- Deadline: 01 Dec 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 774347
- Notice Type: Tender
- Document Ref. No.: UA-2025-11-26-004519-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- A set of reagents for the detection of antibodies to the hepatitis C virus (anti-HCV), compatible with ARCHITECT, Package, 0, research material Plasma, the Architect i2000SR device, Number of tests in the package 2000; A set of reagents for the calibration of the analyzer at high quality determination of antibodies to the hepatitis C virus (anti-HCV), compatible with ARCHITECT, Vial, 1 x 4 ml, research material Plasma, Architect i1000SR device; A set of reagents for checking the calibration of the analyzer in the qualitative determination of antibodies to the hepatitis C virus (anti-HCV), compatible with ARCHITECT, Vial, 2 x 8 ml, research material Plasma, Architect i1000SR device; Hepatitis B Surface Antigen (HBsAg) Reagent Kit Compatible with ARCHITECT, Package, 0, Plasma Test Material, Architect Instrument i2000SR, Number of tests in the package 2000; Set of reagents for Calibrating the analyzer for the qualitative determination of hepatitis B surface antigen (HBsAg), compatible with ARCHITECT, Vial, 2 x 4 ml, research material Plasma, Architect i1000SR device; Set reagents for Detection of analyzer deviations in the qualitative determination of hepatitis B surface antigen (HBsAg), compatible with ARCHITECT, Vial, 2 x 8 ml, research material Plasma, Architect i1000SR device; A set of reagents for the detection of HIV p24 antigen and antibodies to human immunodeficiency virus type 1 and/or type 2 (HIV-1/HIV-2), compatible with ARCHITECT, Package, 0, research material Plasma, Architect i2000SR device, Number of tests per package 2000; A set of reagents ... Purchase type: goods Classifier and its corresponding code: DC 021:2015: 33600000-6 — Pharmaceutical products Kit of reagents for the detection of antibodies to the hepatitis C virus (anti-HCV), compatible with, ARCHITECT, release form, Packaging, 0, research material, Plasma, for the instrument, Architect i2000SR, Number of tests in a package, 2000; A set of reagents for the calibration of the analyzer for the q...
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINA Set of Reagents for the Detection of Antibodies to the Hepatitis C Virus (Anti-Hcv), Compatible with Architect, Package, 0, Research Material Plasma, the Architect I2000Sr Device, Number of Tests in the Package 2000; Nab... - Ukraine Tender
The MUNICIPAL NON-COMMERCIAL ENTERPRISE "ODESA REGIONAL BLOOD TRANSFUSION STATION" OF THE ODESA REGIONAL COUNCIL, a Government sector organization in Ukraine, has announced a new tender for A Set of Reagents for the Detection of Antibodies to the Hepatitis C Virus (Anti-Hcv), Compatible with Architect, Package, 0, Research Material Plasma, the Architect I2000Sr Device, Number of Tests in the Package 2000; Nab.... This tender is published on UkraineTenders under UAT Ref No: 131095467 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-12-01.
The estimated tender value is UAH 774347, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
